Figures
There is an error in Fig 3. Panel ’g’ is missing from Fig 3. Please see the correct Fig 3 here.
(A) Mice were observed after being treated with the peptide on days 1 and 4. (B) Cutaneous viable counts in treated mice. Eight mice per group were euthanized, and the viable counts of the surviving S. aureus bacteria were then determined. (C) Histological morphologies of the skin in treated mice. (a) Normal dorsal skin of mice. (b) Immediately after the skin was scratched. (c) Four days after the skin was scratched. (d) Four days after S. aureus infection in skin treated with Kn2-7. (e) Four days after S. aureus infection in skin treated with BmKn2. (f) Four days after S. aureus infection in skin treated with a placebo. (g) Four days after S. aureus infection in untreated skin. Numbered arrows indicate the following: 1, corneum; 2, epidermis; 3, dermis; and 4, muscular layer.
Reference
- 1. Cao L, Dai C, Li Z, Fan Z, Song Y, Wu Y, et al. (2012) Antibacterial Activity and Mechanism of a Scorpion Venom Peptide Derivative In Vitro and In Vivo. PLOS ONE 7(7): e40135. https://doi.org/10.1371/journal.pone.0040135
Citation: Cao L, Dai C, Li Z, Fan Z, Song Y, Wu Y, et al. (2024) Correction: Antibacterial Activity and Mechanism of a Scorpion Venom Peptide Derivative In Vitro and In Vivo. PLoS ONE 19(12): e0315211. https://doi.org/10.1371/journal.pone.0315211
Published: December 4, 2024
Copyright: © 2024 Cao et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.